Asymchem surges 12%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Asymchem (6821.HK) surged more than 12% in Hong Kong trading, last at HK$120.30.

The stock is up 17.59% over the past six months and up 72.59% year to date. It sits 77.70% above its 52-week low of HK$67.70. The intraday swing reached 12.48%.

The Hang Seng Index is up 2.90% over the past five sessions and down 7.28% year to date.

The pharmaceuticals industry index rose 1.6% over the same period.

The company reported third-quarter 2026 revenue of approximately 1.788 billion yuan, up 24.04% from a year earlier; net income rose 81.49% to about 332 million yuan. Asymchem said newly signed orders maintained double-digit growth and expects a significant increase in fourth-quarter delivery volume, guiding to full-year revenue growth of 19% to 22%.

For the first nine months, revenue totaled approximately 5.395 billion yuan, up 16.52% year-over-year; net income attributable to shareholders was about 852 million yuan, a gain of 6.49%, with basic earnings per share of 2.36 yuan. Bernstein previously raised its price target for the stock.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.